|
Orthologous residues
|
|
P130Cas (human): S437‑p, P130Cas (mouse): S441‑p, P130Cas (rat): S535‑p, P130Cas iso2 (rat): S441‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mass spectrometry
|
|
Disease tissue studied:
breast cancer
|
|
Relevant cell lines - cell types - tissues:
MCF-7 (breast cell), MCF-7 (breast cell) [BCAR3 (human), transgenic]
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
|
|
BCAR3 (human)
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization
|
|
Effect of modification (process):
cell motility, altered
|